Podcasts about proteus digital health

                       "C-CHANGE SHOW - Changing  Business Culture for GOOD."Jeremy Frank and Nelson Mitchell are senior leaders making Swing Tech a huge success in the digital health world. With all the competing priorities of getting funded and scaling, when do you bring in culture? When you're a year in a your whole leadership team looks and thinks like you do, what do you do? Jeremy and Nelson put their egos on the shelf to get into the growing pains of breaking out of homogenized leadership and into creating diversity in their start-up. The elephants will be discussed!A bit more about these rockstars...Jeremy Frank: Runs Operations at Swing and has a long tenure in developing and launching digital-health products. His responsibilities range from launching Swing's virtual-care service to designing and orchestrating Swing's multiple clinical trials that deliver our growing body of clinical evidence. Prior to Swing, Jeremy held executive positions at Proteus Digital Health where he helped develop the technology platform and launched the company's digital-medicines products in the areas of oncology, infectious disease, and cardiometabolic disease. Jeremy holds Masters and Doctorate degrees from the University of California, Berkeley, and an undergraduate degree from Stanford University, all in mechanical engineering. Nelson Mitchell: Nelson is a co-founder and leads the Product and Design teams at Swing Therapeutics, a digital therapeutics company based in San Francisco, CA. Previously, Nelson founded and led Slalom -a San Francisco's based design consulting practice. Over the years, he developed digital products and strategies for leading Bay Area and global companies, across industries from energy to architecture, and from biotech to financial services.Nelson's expertise spans product strategy and management, interaction design, organizational development, and systems thinking. He has a passion for addressing healthcare, environmental and sustainability issues with entrepreneurship, teamwork, and cutting edge technology .Nelson graduated with honors from San Francisco State University's product design masters program, and holds undergraduate degrees in finance and economics from Michigan State University, with additional coursework in politics, philosophy and economics at the University of Oxford.

Arna Ionescu Stoll has deep expertise developing complex, multi-touchpoint healthcare products that integrate seamlessly into people's lives. As the Chief Executive Officer at Wavely Diagnostics, she is guiding Wavely's technology through development and into viable commercial markets based on her decades of experience developing high impact, innovative healthcare products that solve real human needs. Arna has been a part of the digital health community since before the term “digital health” was coined, and she has served as executive, consultant, and senior advisor to various healthcare, digital health, and medical devices companies.Prior to her role at Wavely, she was the founder and principal at Triody, a boutique consulting firm focused exclusively on supporting early stage healthcare companies, the Vice President of User Experience & Design at Proteus Digital Health, a start-up creating digital medicines to support adherence and diagnostics that grew into a billion dollar company before her departure, and a Health Practice lead at IDEO, a global design and innovation consulting firm, where she built IDEO's first “Connected Health” business focused on supporting companies that used technology to facilitate healthcare delivery. Arna holds a B.S.E. in Computer Science and minor in Modern Dance from Princeton University, and an M.S. in Computer Science/Human Computer Interaction from Stanford University."A special episode as Arna and Miles went to elementary school together and Purpose Built is an investor in Wavely.We talked about how to bring a product to market and how to work with academic co founders, how mission driven messages resonate differently with employees and investors and how to build a parent friendly workplace and much, much more.“I think it's really important to find the right investors. I think having people who will support you in building a company, having people that you really enjoy speaking with is much more important than having a check.” - Arna Ionescu StollToday on Startups for Good we cover:Using a cell phone to diagnose an ear infectionBeing realistic about timelinesThe biggest surprise when a client becomes your employerHuman centered design How to seek non-dilutive fundingWorking with academic co-foundersCreating parent friendly work environmentsHow to attract investors and employees with a missionAdvice for female founders and CEOsConnect with Arna on LinkedIn, Twitter and Instagram or on their website.Subscribe, Rate & Share Your Favorite Episodes!Thanks for tuning into today's episode of Startups For Good with your host, Miles Lasater. If you enjoyed this episode, please subscribe and leave a rating and review on your favorite podcast listening app.Don't forget to visit our website, connect with Miles on Twitter or LinkedIn, and share your favorite episodes across social media. For more information about Purpose Built visit our website.

MobiHealthNews founding editor Brian Dolan, now founder and lead writer at Exits and Outcomes, joins the host Jonah Comstock, Managing Editor Laura Lovett, and Associate Editor Dave Muoio for a bit of a post-mortem on Proteus Digital Health, the sensor-enabled pill company that filed for Chapter 11 bankruptcy protection last week.More related to this episode:'Digital pill' maker Proteus Digital Health files for bankruptcyProteus parts ways with Otsuka as it pivots toward oncology, infectious disease treatment adherenceProteus furloughed majority of employees last month after collapse of $100M funding roundThe Proteus Digital Health Report at Exits and Outcomes (subscription required)

Dr. George Savage is the Chief Medical Officer / Co-Founder at Proteus Digital Health, Inc (full disclosure: he's also a member of Ricochet's Board of Directors) and has been closely watching both government's management of the Corona crisis, the evolution of the testing protocols, and the search for a treatment and ultimately, a vaccine. In this conversation with Rob Long, Dr. Source

Dr. George Savage is the Chief Medical Officer / Co-Founder at Proteus Digital Health, Inc (full disclosure: he’s also a member of Ricochet’s Board of Directors) and has been closely watching both government’s management of the Corona crisis, the evolution of the testing protocols, and the search for a treatment and ultimately, a vaccine. In […]Join the conversation and comment on this podcast episode: https://ricochet.com/podcast/ricochet-podcast/ask-dr-savage/.Now become a Ricochet member for only $5.00 a month! Join and see what you’ve been missing: https://ricochet.com/membership/.Subscribe to Ricochet Podcast in Apple Podcasts (and leave a 5-star review, please!), or by RSS feed. For all our podcasts in one place, subscribe to the Ricochet Audio Network Superfeed in Apple Podcasts or by RSS feed.

Digital medicines are drugs that when ingested communicate to a consumer's mobile device and report the time of ingestion, along with accurate metrics of activities of daily life collected by a wearable patch and communicated using the patient’s mobile device. Digital medicine solutions engage patients, families and providers, delivering accurate feedback that enhances trust, improves collaboration and delivers much better, personalized outcomes. In this episode, Andrew Thompson, CEO of Proteus Digital Health, will explain why this new category - digital medicines - is a sector that will generate revenues of $100B within ten years, and within 30 years why every drug in the world will be a digital medicine. Remember that you can hear and meet speakers like Andrew live by attending Frontiers Health. Visit Frontiers.Health to find out about upcoming events taking place around the world, and come meet the team and others working to transform healthcare at the annual conference held each November in Berlin.  Find all the episodes on the Health Podcast Network where you can also find links to the series on your favorite podcast players. Be sure to hit subscribe so you can find new episodes as they go live.

Episode 4 features Dr. George Savage, co-founder and Chief Medical Officer of Proteus Digital Health.  Together with Dr. Kvedar, they discuss the evolution of sensor technology, digital medicines and the appeal of the healthcare and digital space for entrepreneurs. Click Here to Listen to More Episodes of Well / Connected

On Episode #7 we talk about digital pills and some of the associated ethical concerns with this new product that's already on the U.S. market. Show note links and additional reading on digital pills: NY Times article "First Digital Pill Approved to Worries About Biomedical Big Brother" by Pam Belluk Wikipedia blurb about Otsuka Pharmaceutical, makers of Abilify Press release from Proteus Digital Health's website that announced the FDA approval on the digital pill Abilify MyCite, a collaborative effort between Proteus and Otsuka Pharmaceutical Healthcare Analytics News article by Ryan Black "Can the Digital Pill Quiet Pharma's R&D Nightmares?" Forbes article by the Forbes Technology Council "The Potential Consequences of the New FDA-approved Digital Pill" In the News (a brand new segment debuting on the show today!): Check out what Worcester Polytechnic Institute (aka WPI) students and their professor are doing by Using Data Science to Help Predict Adverse Drug Reactions by Thomas Coakley Roseanne Barr blames a prescription drug for her controversial tweet that lit up the Twitterverse and beyond, Vulture article by Hunter Harris New published research data on synthetic drugs vs. opioids and which one (spoiler alert***** synthetic drugs) caused more deaths in 2016, article by Steven Ross Johnson As always, to reach us: email -- talk(at)overprescribedpodcast.com / Twitter: @_overprescribed

Last month Otsuka Pharmaceutical and Proteus Digital Health won U.S. Food and Drug Administration approval for what's being hailed as the first digital pill. Abilify Mycite, a drug-device combination that marries Otsuka's Abilify, used to treat schizophrenia, with Proteus' ingestible sensor, wearable sensor, and smartphone app intended to monitor and improve compliance. We spoke to George Savage, chief medical officer of Proteus, about the technology, other potential uses, and how it may help address the quality and cost of healthcare.

Today in FirstWord:

Adam, Jackie and Katie: Ten of the most innovative companies in healthcare, wellness initiatives that have experienced great results and those that come off as slimy.